NASDAQ: ZYBTZhengye Biotechnology Holding Revenue
Zhengye Biotechnology Holding revenue was $17.06M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ZYBT annual revenue was $16.5M, with -35.3% growth year-over-year.
ZYBT past revenue growth
How has ZYBT's revenue growth performed historically?
Company
-35.25%
Industry
4.35%
Market
76%
ZYBT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ZYBT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ZYBT revenue history
Current Revenue
$16.5M
Current Earnings
-$9.9M
Current Profit Margin
-60%
Be the first to know when ZYBT announces revenue.
ZYBT Revenue History By Year
| ZYBT Yearly Revenue | ZYBT Revenue | ZYBT Change | ZYBT Revenue Growth |
|---|---|---|---|
| 2025-12-31 | $16.53M | -$9.00M | -35.25% |
| 2024-12-31 | $25.53M | -$4.32M | -14.48% |
| 2023-12-31 | $29.85M | -$7.49M | -20.06% |
| 2022-12-31 | $37.34M | N/A | N/A |
Zhengye Biotechnology Holding Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.